日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

评估复发性肉瘤患儿接受树突状细胞免疫疗法后的免疫反应

Lenka Fedorova ,Peter Mudry,Katerina Pilatova ,Iveta Selingerova,Jana Merhautova,Zdenek Rehak ,Dalibor Valik ,Eva Hlavackova,Dasa Cerna,Lucie Faberova,Pavel Mazanek,Zdenek Pavelka,Regina Demlova,Jaroslav Sterba ,Lenka Zdrazilova-Dubska

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome

树突状细胞免疫疗法在晚期肉瘤和神经母细胞瘤儿童患者中的应用:单核细胞采集前的抗癌治疗会损害树突状细胞的免疫刺激和抗原呈递行为以及生产工艺结果

Hlavackova, Eva; Pilatova, Katerina; Cerna, Dasa; Selingerova, Iveta; Mudry, Peter; Mazanek, Pavel; Fedorova, Lenka; Merhautova, Jana; Jureckova, Lucie; Semerad, Lukas; Pacasova, Rita; Flajsarova, Lucie; Souckova, Lenka; Demlova, Regina; Sterba, Jaroslav; Valik, Dalibor; Zdrazilova-Dubska, Lenka

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

MiR-215-5p 是一种针对 EGFR 配体表皮调节蛋白及其转录诱导剂 HOXB9 的结肠直肠癌肿瘤抑制因子

Petra Vychytilova-Faltejskova, Jana Merhautova, Tana Machackova, Irene Gutierrez-Garcia, José Garcia-Solano, Lenka Radova, Dominika Brchnelova, Katerina Slaba, Marek Svoboda, Jana Halamkova, Regina Demlova, Igor Kiss, Rostislav Vyzula, Pablo Conesa-Zamora, Ondrej Slaby

MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers

在特定胃肠道癌症动物模型中应用microRNA疗法

Merhautova, Jana; Demlova, Regina; Slaby, Ondrej

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib

miR-155 和 miR-484 与舒尼替尼治疗转移性肾细胞癌的疾病进展时间相关

Merhautova, Jana; Hezova, Renata; Poprach, Alexandr; Kovarikova, Alena; Radova, Lenka; Svoboda, Marek; Vyzula, Rostislav; Demlova, Regina; Slaby, Ondrej